₹432.30
0.20 (0.05%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹7.04K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
25.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹312.95+38.1%
52W High₹527.8-18.1%
Current Price
₹432.30
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹345.84
Upper Circuit₹518.76
Reference Price
₹432.30
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹451.02
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹354.4
Trend: Price above all key MAs — strong uptrend
Golden Cross detected 2 day(s) ago
Volume divergence: Bearish (price up, volume down)
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
88%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
415.73
EMA50
397.21
EMA200
405.92
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows6
Lower Highs5
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹440.28
₹453.70
₹463.55
₹476.70
₹496.80
Support (Below)
₹431.80
₹422.00
₹404.85
₹399.50
₹389.00
Volume Analysis
TrendDECREASING
Change-15.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent MA Crossovers
Golden Cross
2 days ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹427.98
3% Risk₹419.33
5% Risk₹410.69
7% Risk (Custom)
₹402.04Technical Levels
1x ATR (Volatility)₹418.05
2x ATR (Swing)₹403.80
3x ATR (Trend)₹389.55
Immediate Support₹431.80
Moving Averages
EMA 9 (Short-term)₹426.35
EMA 20 (Medium-term)₹415.73
EMA 50 (Trend)₹397.21
EMA 200 (Long-term)₹405.92
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹486.3 Cr | ₹648.4 Cr | ₹473 Cr | ₹464.7 Cr |
| Net Profit | ₹38.7 Cr | ₹121.4 Cr | ₹28.4 Cr | ₹28.3 Cr |
| EPS | — | ₹7.45 | ₹1.75 | ₹1.74 |
| Operating Profit | ₹69.3 Cr | ₹175.8 Cr | ₹54.4 Cr | ₹52.3 Cr |
ROE
11.70%
ROCE
15.68%
Debt/Equity
0.01
Current Ratio
3.01
OPM
11.25%
NPM
6.09%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| FDC Limited | ₹432.30 | +0.05% | 25.0 | ₹7.04K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 11 Feb 2026 | Interim Dividend - Rs 5 Per Share | INTERIM_DIVIDEND |
| 22 Nov 2024 | Interim Dividend - Rs 5 Per Share | INTERIM_DIVIDEND |
| 19 Sept 2024 | Annual General Meeting | AGM |
| 20 Sept 2023 | Annual General Meeting | AGM |
| 25 Aug 2023 | Buy Back | BUYBACK |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for FDC
View All
negative
NDTV Profit 20d ago
Centre Prohibits Sale, Distribution Of 16 Fixed-Dose Combination Drugs
The Ministry banned the FDC in the notifications issued under Section 26A.
FDCHealthcare
NEWS
positive
Business Standard - Markets 44d ago
FDC consolidated net profit rises 167.39% in the March 2026 quarter
Sales rise 18.89% to Rs 584.79 crore
FDCHealthcare